🇺🇸 Dexamphetamine in United States

111 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Ineffective — 19 reports (17.12%)
  2. Fatigue — 15 reports (13.51%)
  3. Nausea — 13 reports (11.71%)
  4. Dizziness — 11 reports (9.91%)
  5. Depression — 10 reports (9.01%)
  6. Headache — 10 reports (9.01%)
  7. Aggression — 9 reports (8.11%)
  8. Anxiety — 8 reports (7.21%)
  9. Insomnia — 8 reports (7.21%)
  10. Toxicity To Various Agents — 8 reports (7.21%)

Source database →

Dexamphetamine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is Dexamphetamine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Dexamphetamine in United States?

The Netherlands Cancer Institute is the originator. The local marketing authorisation holder may differ — check the official source linked above.